Clinical Trials Logo

Dystonic Disorders clinical trials

View clinical trials related to Dystonic Disorders.

Filter by:

NCT ID: NCT05502718 Recruiting - Dystonia, Cervical Clinical Trials

Exercise Program for Patients With Cervical Dystonia Who Are Treated With Botulinum Toxin Type A

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Dystonia is involuntary movements characterized by posture abnormalities or repetitive movements as a result of continuous or intermittent simultaneous contraction of opposing muscle groups. Dystonic movements are twisted and twisted in a certain pattern. Dystonia is named in different ways according to its distribution in the body. Cervical dystonia is the most common form of regional dystonia and can be defined as involuntary movements of the head in normal upright posture.Cervical dystonia has different names according to the posture of the neck (torticollis, laterocollis, anterocollis and retrocollis). These different postures can be seen individually as well as together.Pain in cervical dystonia is seen in approximately 70% of patients, and this condition is closely related to involuntary contractions of neck muscles and neck posture disorder. Fatigue, anxiety, unhappiness, decreased self-efficacy and limitation in daily living activities due to decreased neck movements are the main causes of disability in patients with cervical dystonia. The first-line treatment of cervical dystonia consists of injecting botulinum toxin type A into the relevant muscles to alleviate these complaints.There is increasing evidence that range of motion, stretching, and relaxation exercises, in addition to botulinum toxin therapy, have beneficial effects on pain and disability in patients with cervical dystonia.In this study, patients with cervical dystonia who received botulinum toxin type A injection will be divided into study group and control group.The patients in the study group will be given stretching, strengthening, breathing and rhythmic coordination exercises for the muscles involved. (Personalized exercise program) In the control group, only breathing and rhythmic coordination exercises will be given and the two groups will be compared.Thus, it is aimed to investigate the effect of a personalized exercise program on clinical findings and the patient's quality of life.

NCT ID: NCT05467228 Not yet recruiting - Laryngeal Dystonia Clinical Trials

Laryngeal Vibro-tactile Stimulation as a Non-invasive Symptomatic Treatment for Spasmodic Dysphonia

Start date: January 1, 2025
Phase: Phase 2
Study type: Interventional

The general aim of the research is to provide scientific evidence that vibro-tactile stimulation (VTS) represents a non-invasive form of neuromodulation that can induce measurable improvements in the speech of patients with laryngeal dystonia (LD) - also called spasmodic dysphonia (SD).

NCT ID: NCT05416905 Recruiting - Clinical trials for Deep Brain Stimulation

Deep Brain Stimulation for Idiopathic Craniofacial Dystonia: GPi or STN

MEIGES
Start date: June 22, 2022
Phase: N/A
Study type: Interventional

MEIGES is a prospective, multicenter, randomized controlled clinical trial with the primary hypothesis that, STN-DBS is non-inferior to GPi-DBS for motor symptoms improvements at 365 days postoperatively in patients with idiopathic craniofacial dystonia.

NCT ID: NCT05327985 Not yet recruiting - Cervical Dystonia Clinical Trials

Three-dimensional Analysis of Obliquus Capitis Inferior Muscle Function in the Rotatory Form of Cervical Dystonia by Means of the Cone Beam

STOCI
Start date: January 2024
Phase:
Study type: Observational

Cervical dystonia is the most common form of focal dystonia in adults (50-82%). It manifests itself by a abnormal attitude of the head, intermittent or permanent, due to involuntary contraction of the cervical muscles which appears or is accentuated on the occasion of voluntary movement and maintenance posture. The distribution of dystonic muscles is specific to each patient explaining the diversity of patterns encountered. The therapeutic management of DC is essentially local and symptomatic. It is based on the realization of injections of neuro botulinum toxin (BoNT) targeting target (dystonic) muscles responsible for involuntary movements or posture abnormal. Identifying the muscles involved is a step prerequisite for therapeutic intervention.The obliquus capitis inferior (OCI) also known as Lower Oblique belongs to the group of suboccipital muscles.It is the only suboccipital muscle that does not attach to the skull. Its unilateral contraction causes ipsilateral rotation of C1 therefore of the head. The length of the transverse process of the atlas gives it considerable rotary efficiency. It is described as the cephalic rotation starter muscle. It would perform the 30 first degrees of rotation. The rotation of the whole column cervical would then be continued by the synergistic action of the muscle contralateral sternocleidomatoid and Spl. ipsilateral. The level of joint complex C1-C2 the amplitude of rotation corresponds to approximately 50% of the total rotation of the cervical spine. In order to better understand the part played by the OCI muscle in the disorganization of posture and cervical movements in the axial plane (plane of rotation) in the rotary DC, the investigators want biomechanically analyze its function in pathological situation. The physiology of this muscle is richly documented in healthy subjects. But does this knowledge apply in DC? Acquisition of imagery by the "Cone Beam" or CBCT system (Cone Beam Computed Tomography) before and 5 weeks after the injection of BoNT, will allow the analysis of the displacement of each vertebrate.

NCT ID: NCT05317390 Recruiting - Parkinson Disease Clinical Trials

Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

This research involves retrospective and prospective studies for clinical validation of a DystoniaNet deep learning platform for the diagnosis of isolated dystonia.

NCT ID: NCT05216770 Recruiting - Tremor Clinical Trials

Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor

Start date: March 24, 2022
Phase: Early Phase 1
Study type: Interventional

The researchers will examine functional neural correlates that differentiate between laryngeal dystonia and voice tremor and contribute to disorder-specific pathophysiology using a cross-disciplinary approach of multimodal brain imaging.

NCT ID: NCT05179811 Recruiting - Clinical trials for Functional Dystonia (Disorder)

Description of the Evolution of Functional Dysphonia Managed by Hypnotherapy

HYPNODYS
Start date: April 8, 2022
Phase:
Study type: Observational

HYPNODYS is a single-center study evaluating the evolution of perceived voice-related disability before and after 3 standardized hypnosis sessions in patients with functional dysphonia.

NCT ID: NCT05157100 Completed - Cervical Dystonia Clinical Trials

Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia

Start date: October 19, 2021
Phase: Phase 4
Study type: Interventional

Study of Ingrezza (Valbenazine) for the treatment of cervical dystonia.

NCT ID: NCT05150106 Recruiting - Tremor Clinical Trials

Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor

Start date: November 7, 2022
Phase:
Study type: Observational

The researchers will systematically evaluate current and novel clinical voice assessment tools and measures to elucidate distinct clinical phenotypes of those with laryngeal dystonia and voice tremor.

NCT ID: NCT05150093 Recruiting - Dystonia Clinical Trials

Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor

Start date: June 21, 2022
Phase: N/A
Study type: Interventional

The goals of this project are 1) to determine the incidence of neurological voice disorders in patients with dystonia and essential tremor undergoing deep brain stimulation (DBS), 2) investigate the neuroimaging and intracranial neurophysiology correlates of voice dysfunction in these subjects, and subsequently 3) determine the effects of DBS on voice function.